Search

Your search keyword '"Ye, Lei"' showing total 1,683 results

Search Constraints

Start Over You searched for: Author "Ye, Lei" Remove constraint Author: "Ye, Lei" Database Unpaywall Remove constraint Database: Unpaywall
1,683 results on '"Ye, Lei"'

Search Results

5. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D

7. GS-002 48-week off-therapy efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: final results from the phase 2b, open-label, randomised, multicentre study MYR204

8. FRI-371 Undetectable HDV RNA at 24 weeks of treatment with combination therapy is an important predictor of maintained response off-therapy

9. WED-395 Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic response in chronic hepatitis delta

14. Molecular Level Simulation of the Conversion and Distribution of Sulfides in the Fluid Catalytic Cracking and Hydrotreating Processes to Improve the Cleanliness of Gasoline and Diesel

17. Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics

20. MP62-18 RETREATMENT RATES ASSOCIATED WITH MINIMALLY INVASIVE SURGICAL THERAPY FOR BPH/LUTS: FINDINGS FROM THE UROLOGIC DISEASES IN AMERICA PROJECT

23. Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors

25. Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes

33. Myoblast Therapies Constitute a Safe and Efficacious Platform Technology of Regenerative Medicine for the Human Health Industry

34. Myoblast Therapies Constitute a Safe and Efficacious Platform Technology of Regenerative Medicine for the Human Health Industry

36. Contributors

46. COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment

Catalog

Books, media, physical & digital resources